Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

Editorial [Hot topic: Infective Endocarditis (Guest Editor: Ioannis Starakis)] promotion: free to download

Volume:9   Issue: 4
Pp: 230-230
Ioannis Starakis
DOI: 10.2174/1871529X10909040230

Odontogenic Infections in the Etiology of Infective Endocarditis

Volume:9   Issue: 4
Pp: 231-235
Antonio Bascones-Martinez, Marta Munoz-Corcuera and Jukka H. Meurman
DOI: 10.2174/1871529X10909040231

Prevention of Bacterial Endocarditis

Volume:9   Issue: 4
Pp: 236-239
Elias E. Mazokopakis, Christos M. Karefilakis and Ioannis K. Starakis
DOI: 10.2174/1871529X10909040236

Complications of Infective Endocarditis

Volume:9   Issue: 4
Pp: 240-248
R. Mocchegiani and M. Nataloni
DOI: 10.2174/1871529X10909040240

Prosthetic Valve Endocarditis: Diagnostic Approach and Treatment Options

Volume:9   Issue: 4
Pp: 249-260
Ioannis Starakis and Elias E. Mazokopakis
DOI: 10.2174/1871529X10909040249

Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)

Volume:9   Issue: 4
Pp: 261-270
Alessandra Quercioli, Fabrizio Montecucco and Francois Mach
DOI: 10.2174/1871529X10909040261

A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis open access plus

Volume:9   Issue: 4
Pp: 271-292
Robert P. Hebbel, Greg M. Vercellotti and Karl A. Nath
DOI: 10.2174/1871529X10909040271

CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?

Volume:9   Issue: 4
Pp: 293-302
Alexandra Krettek and Sara Sjoberg
DOI: 10.2174/1871529X10909040293